Transcatheter intraarterial therapies: rationale and overview - Wikidata - awgldk - TriplyDB

Transcatheter intraarterial therapies: rationale and overview

Transcatheter intraarterial therapies: rationale and overview

http://www.wikidata.org/entity/Q36104314

about

Drug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinoma Drug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinoma Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions Cancer concepts and principles: primer for the interventional oncologist-part II Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy Hepatocellular carcinoma: a review Yttrium-90 microspheres: a review of its emerging clinical indications How I do it: Cone-beam CT during transarterial chemoembolization for liver cancer Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes Alginate Microspheres Containing Temperature Sensitive Liposomes (TSL) for MR-Guided Embolization and Triggered Release of Doxorubicin Perspective: Flicking with flow: Can microfluidics revolutionize the cancer research?Innovation in catheter design for intra-arterial liver cancer treatments results in favorable particle-fluid dynamics.Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations Portal vein embolization: rationale, technique, and current application.The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging Markers Science to practice: Which approaches to combination interventional oncologic therapy hold the greatest promise of obtaining maximal clinical benefit?Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization.Radioactive holmium acetylacetonate microspheres for interstitial microbrachytherapy: an in vitro and in vivo stability study.Science to practice: what do molecular biologic studies in rodent models add to our understanding of interventional oncologic procedures including percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists?Hepatocellular carcinoma: natural history, current management, and emerging tools.A Novel Inherently Radiopaque Bead for Transarterial Embolization to Treat Liver Cancer - A Pre-clinical Study.Microvascular Perfusion Changes following Transarterial Hepatic Tumor Embolization.Celiac artery stenting to facilitate hepatic yttrium-90 radioembolization therapy.Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?Transcatheter intra-arterial infusion of doxorubicin loaded porous magnetic nano-clusters with iodinated oil for the treatment of liver cancer Hepatic transarterial chemoembolization and retroperitoneal lymph node radiofrequency ablation in the multidisciplinary approach of an overt metastatic leiomyosarcoma Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study 3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival.Acidic pH-Triggered Drug-Eluting Nanocomposites for Magnetic Resonance Imaging-Monitored Intra-arterial Drug Delivery to Hepatocellular Carcinoma.Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis.Selective Interarterial Radiation Therapy (SIRT) in Colorectal Liver Metastases: How Do We Monitor Response?Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies.Transarterial sorafenib chemoembolization: preliminary study of technical feasibility in a rabbit model.Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography.

P2860

Q24187663-B4B019C2-FDBD-4DDC-A335-59AD9BEA0B4C Q24202061-7C2DF101-EE33-4207-A37C-8CA67F30CA44 Q26851627-3B2D8A00-DE53-4C2B-A311-F9C32B9515CA Q27007847-4886B864-D31D-4294-BA15-319EC9313D56 Q27010961-06CC1A9F-0708-4187-8B9C-FBF717A57573 Q27015918-7D9BAE53-1581-4D82-84D0-6C6536BAA2BE Q28069290-7EE1BCBB-A719-447F-8AA2-EE88FE7D3408 Q28083856-A2A8A5A0-2E54-4C8C-B2E4-EE3573423A48 Q28087066-115FE472-DAFC-4042-BAEB-A7ED90BC5016 Q28538311-B839F2CD-EF63-487B-AB17-14FF230AF6B6 Q28550901-138B205A-1599-4A97-B3FB-426907AFB9F2 Q30443756-A18E038B-C996-4970-BEBE-B57480CFA6E6 Q30659636-161AAFBF-9A70-400B-AE07-CC81CBF26F0C Q34134852-4916A184-553F-4DA4-B5CA-64561DDBB735 Q34652519-E4ACA1A9-896E-4C7E-8BD4-DC98B3B9EA00 Q34826535-28431079-FFA5-413C-8740-D859BE2B3164 Q35537007-53740D8F-10DA-4E4E-9B0F-35F647B333CC Q35560995-506FEA8F-EB35-4447-B8E0-FC834218D1A2 Q35570801-2EC6C71A-4DF6-48DF-8EF5-7FB4660EE369 Q35672442-E1133183-B433-4FC3-98F4-0E2407FA6EEC Q35761648-75F119A8-C449-417C-84D7-FB5E7D17BE33 Q35773556-4FDEFD7D-97AE-436B-A46C-D50B17B5165F Q36171275-461A828D-6C4F-44DF-A66E-E5CC2891E1AD Q36372328-FDE40F42-6BA3-4EA8-B9C5-F8075E9AF0B5 Q36421800-A4A7D525-3E9C-44B6-B5C3-295358B7C03F Q36470428-FCE2E9A1-1CCC-4D37-85A4-0085DE389F57 Q36687966-E561F1C6-3E9B-4484-8668-EB4007D1C6CB Q36689688-7EBB0AAF-4D32-4EDB-B9F8-0CAEE75B7421 Q36733086-124CFC11-63DF-4A3D-9248-7171A8BC39D5 Q37075313-679654DD-5ACA-47B8-807D-DE53B0A0699B Q37088693-A9C48A29-8465-4D7D-8A29-4214767BD03F Q37092372-0FEACBC0-636E-42E9-AE20-FCABAA9BF96A Q37114870-0CB4C14C-76FD-4400-8A9F-CCE5FAE065C4 Q37253841-06E0063B-9259-4F8C-93F2-59E20C0982FE Q37316201-DE44A1D4-9C4D-4F41-BA55-8A9468E1E0E8 Q37601096-0A953AD8-1C19-4DE1-8FC8-5B99F26CAEF3 Q37669068-8BF536A1-4817-4E50-A248-6650DF6BA328 Q37695686-F2FC3B96-9C31-4E1D-8417-D309B4A77A49 Q37704703-982933C1-52B3-4271-97E9-8DB9839A3391 Q37716190-E1B794C5-A442-481D-B006-F5BE829F319E

P2860

Transcatheter intraarterial therapies: rationale and overview

http://www.wikidata.org/entity/Q36104314

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Transcatheter intraarterial therapies: rationale and overview

@ast

Transcatheter intraarterial therapies: rationale and overview

@en

type

label

Transcatheter intraarterial therapies: rationale and overview

@ast

Transcatheter intraarterial therapies: rationale and overview

@en

prefLabel

Transcatheter intraarterial therapies: rationale and overview

@ast

Transcatheter intraarterial therapies: rationale and overview

@en

P1433

Q36104314-3DCBDF04-0751-434A-AF1E-F8A92B520956

P1476

Q36104314-65D9CC71-C8B1-461D-A398-34D2C0997485

P2093

Q36104314-363794DF-088A-4CA9-AFE7-D834502DCF1A

Q36104314-45E5DE00-867B-4C99-B94A-B021168E918C

Q36104314-899178B2-A51B-4CB3-9C00-2296AB902D83

Q36104314-B6C4DD88-0F95-4523-BF10-A3B1DD179968

P2860

Q36104314-005E0DB8-97E2-4DB6-BE6A-2695CF9C4E8E

Q36104314-00E610B6-D07F-446F-B56D-9C74F7A4D019

Q36104314-02364C97-D863-4955-9B43-E3767F74059E

Q36104314-05916C56-F6E7-4109-865E-3337A6708B22

Q36104314-0B3DAC69-CF3F-4C79-8934-8A64F1FD267B

Q36104314-0BA901F9-9A35-44C9-95B6-B94FA805D4C4

Q36104314-0E781CF6-704C-44C2-910C-8B979F824970

Q36104314-0F78C124-CA12-4B96-921F-8C42852287FD

Q36104314-10D07B8D-D454-4F83-829D-39F51CD4CB39

Q36104314-17744069-B950-464B-AD14-C9A71C37F425

P304

Q36104314-AD299E82-96E6-46A4-8D15-F051F74FE339

P31

Q36104314-10BF99FE-878D-4BC9-9DF0-BA622F123A34

P356

Q36104314-AFA877E3-86BA-462D-986A-6293525140D0

P407

Q36104314-895C6730-F851-48C6-9ED8-88BAE51559AC

P433

Q36104314-BCA255D8-4412-4A42-96B1-504E73AF8D32

P478

Q36104314-EB6CB777-24CE-4CB8-A577-A9F9441BB687

P577

Q36104314-F0453E86-0EEA-4BFD-804A-DE6E75BAE3D2

P5875

Q36104314-5BA745B3-84CF-4239-8C81-30EFFC83635A

P698

Q36104314-E6066D08-1736-4C8D-9714-48FCC050CB54

P932

Q36104314-030281B5-36B1-4450-9D00-F78D36157874

P356

RADIOL.11081489

P1433

P1476

Transcatheter intraarterial therapies: rationale and overview

@en

P2093

Eleni Liapi

http://www.w3.org/2001/XMLSchema#string

Jean-Francois Geschwind

http://www.w3.org/2001/XMLSchema#string

Riad Salem

http://www.w3.org/2001/XMLSchema#string

Robert J Lewandowski

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Yttrium-90 microspheres: radiation therapy for unresectable liver cancer

Lysyl oxidase is essential for hypoxia-induced metastasis

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Reporting results of cancer treatment

Preoperative superselective arteriolar embolization: a new approach to enhance resectability of spinal tumors.

Pre-operative transarterial embolization for treatment of primary sacral tumors.

Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a Phase II-study and historical comparison with the surgical approach.

P304

641-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.11081489

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

259

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51156100

http://www.w3.org/2001/XMLSchema#string

P698

21602502

http://www.w3.org/2001/XMLSchema#string

P932

3400295

http://www.w3.org/2001/XMLSchema#string